Friday, 2nd August
The Melbourne Immunotherapy Network Winter Symposium 2019
Days
Friday, 2nd August
Saturday, 3rd August
Search
Speakers
Registration Opens
12:00PM - 2:00PM
Friday, 2nd August
Cuzens Pre Function foyer
Session 1 - Clinical Cancer Immunotherapy
2:00PM - 3:45PM
Friday, 2nd August
Kooringa-Kitchener rooms
Chair: Andreas Behren
Is there a role for cancer vaccines in the checkpoint and CAR-T immunotherapy era?
-
Riccardo Dolcetti
Mutational sculpting during melanoma evolution to end-stage disease
-
Mark Shackleton
Spliced peptides are an abundant and immunogenic component of the melanoma immunopeptidome.
-
Andreas Behren
Epigenetic repression of MHC class I antigen presentation enables immune evasion in cancer
-
Marian L Burr
Utilizing tumor-intrinsic IFN signaling to predict and prevent prostate cancer progression in bone
-
Katie Owen
Afternoon Tea
3:45PM - 4:10PM
Friday, 2nd August
Keppel-Maryland-Cumberland rooms
Session 2 - Cancer Genetics and Immunity
4:10PM - 5:15PM
Friday, 2nd August
Kooringa-Kitchener rooms
Chair: Nicholas Huntington
Investigating the role of breast cancer susceptibility variants in immune surveillance
-
Georgia Chenevix-Trench
Targeting innate immune pattern recognition receptors in upper gastrointestinal cancers
-
Brendan Jenkins
Loss of NF-kB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner
-
Lorraine A O'Reilly
Session 2 - Short Fast Loud Talks
5:15PM - 5:55PM
Friday, 2nd August
Kooringa-Kitchener rooms
Chair: Nicholas Huntington
Differential targeting of IFNγ- and IL-17-producing tissue-resident memory CD8
+
T cells
-
Simone L Park
Regulation of breast cancer metastasis by G-CSF
-
Kellie A Mouchemore
A novel murine model to study immune control in primary melanoma and metastatic disease
-
Katharina Hochheiser
Exploring natural killer cell infiltration and activity in solid tumours through bulk sequencing data
-
Joe Cursons
Posters, Trade Display & Drinks
6:00PM - 7:30PM
Friday, 2nd August
Keppel-Maryland-Cumberland rooms
An immunomodulatory role for IL-11 in colon cancer
-
Jennifer Huynh
γδ- Intraepithelial lymphocytes(γδ- IELs) of the colon: are they potential targets for immunotherapy in colorectal cancer?
-
Dinesh Raghu
Overcoming Tumor Resistance to Adaptive Immunotherapy by Enhancing CTL Function and Disturbing the Tumor Microenvironment
-
Tinaz Samiei
Macrophage-derived CXCL9 and CXCL10 are critically required for anti-tumor immune responses following immune checkpoint blockade
-
Imran House
DNA methyltransferase 3a (DNMT3A) promotes inflammation‑associated gastric cancer growth
-
Anne Huber
Selective Stat3 inhibition in the tumour microenvironment restricts gastrointestinal tumour growth
-
Mariah MA Alorro
Understanding the role of a unique population of T-helper 17 cells in the pathogenesis of infection-induced colon cancer
-
Ka Yee Fung
Investigating the role of gp130/STAT3 signalling in intestinal barrier function
-
Lokman Pang
Early memory T cells propagate exhaustion during chronic infection
-
Daniel T Utzschneider
ENHANCING RESPONSES TO CANCER VACCINES AND IMMUNOTHERAPIES – IFNβ AS A NOVEL ADJUVANT
-
Teagan Wagner
AUTOCRINE LAMININ-511 IN TRIPLE NEGATIVE BREAST CANCER IMMUNOBIOLOGY
-
Elnaz Tavancheh
Analysis of TCF1 expression in T cells and colon cancer progression
-
Anita Kumari
Identifying the optimal binding motif of CpG oligonucleotides for DEC-205 to improve adjuvant potency
-
Irina Caminschi
Dissection of prostate tumour, stroma and immune transcriptional components reveals a key contribution of the microenvironment for disease progression
-
Stefano Mangiola
Towards a universal Mucosal-Associated Invariant T (MAIT) CELL-based vaccination for better protection against microbial infections
-
Zhenjun Chen
Dinner
7:30PM - 10:00PM
Friday, 2nd August
Radius Restaurant
Post Dinner Networking
10:00PM - 11:30PM
Friday, 2nd August
Radius Restaurant
Saturday →